 The global increase in treatment failure for old and new world leishmaniasis is due to drug resistance and the impact of HIV aids on the immune system and requires urgent re-evaluation of treatment guidelines. This article was authored by Alisha Ponte-Sukar, Francisco Gamarro, Jean-Claude Duzardin and others.